New York TimesLean L·
Moderna’s Shift to Cancer Company Lifts Stock Up 177%
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Read at New York Times →
US · 2 sources covering this
Moderna’s Shift to Cancer Company Lifts Stock Up 177%
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Coverage spectrum
2 L · 0 C · 0 R
How 2 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/81f1f597f61ddda99fa8121d00aba5b448c10eef" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Moderna’s Shift to Cancer Company Lifts Stock Up 177%"></iframe>
